De potentielle fordele for moderen og risikoen for barnet skal overvejes før administration af Prepandemisk influenzavaccine GlaxoSmithKline i ammeperioden.
The potential benefits to the mother and risks to the infant should be considered before administering Prepandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals 3.75 µg during lactation.